Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- The study was conducted between 20 December 2018 and 31 January 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 019
- Report date:
- 2019
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.1 bis (Acute Oral Toxicity - Fixed Dose Procedure)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.1100 (Acute Oral Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agriculture, Forestry and Fisheries, Test Data for Registration of Agricultural Chemicals, Acute oral toxicity (2-1-1), 12 Nousan No 8147, Agricultural Production Bureau, November 24, 2000.
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- fixed dose procedure
- Limit test:
- yes
Test material
- Reference substance name:
- Silicon
- EC Number:
- 231-130-8
- EC Name:
- Silicon
- Cas Number:
- 7440-21-3
- Molecular formula:
- Si
- IUPAC Name:
- Silicon
- Reference substance name:
- Magnesium silicate
- EC Number:
- 237-413-2
- EC Name:
- Magnesium silicate
- Cas Number:
- 13776-74-4
- Molecular formula:
- H2O3Si.Mg
- IUPAC Name:
- magnesium(2+) ion oxosilanebis(olate), crystalline
- Reference substance name:
- Silicon dioxide
- EC Number:
- 231-545-4
- EC Name:
- Silicon dioxide
- Cas Number:
- 7631-86-9
- Molecular formula:
- O2Si
- IUPAC Name:
- Silicon dioxide, amorphous
- Reference substance name:
- Dimagnesium silicate
- EC Number:
- 233-112-5
- EC Name:
- Dimagnesium silicate
- Cas Number:
- 10034-94-3
- Molecular formula:
- Mg2O4Si
- IUPAC Name:
- dimagnesium silicate
- Reference substance name:
- Carbon
- EC Number:
- 231-153-3
- EC Name:
- Carbon
- Cas Number:
- 7440-44-0
- Molecular formula:
- C
- IUPAC Name:
- Carbon
- Reference substance name:
- Metallic impurities (Na and S)
- IUPAC Name:
- Metallic impurities (Na and S)
- Test material form:
- solid: particulate/powder
Constituent 1
Constituent 2
Constituent 3
Constituent 4
impurity 1
impurity 2
- Specific details on test material used for the study:
- Test item: Reaction mass of crystalline magnesium silicate and crystalline silicon and synthetic amorphous silicon dioxide
Alternative name: Mg-SiO
Reaction mass of MgSiO3, Si and SiO2
Appearance: Black powder
Storage conditions: Ambient temperature (10-30°C) in the dark
Supplier: Sponsor
Batch number: Y180510A
Expiry/Retest date: 31 May 2019
Purity: > 94%
Test animals
- Species:
- rat
- Strain:
- Wistar
- Remarks:
- RccHan:WIST albino rats
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- Animal Information:
Healthy nulliparous and non-pregnant female RccHan™:WIST albino rats were obtained from Envigo RMS (UK) Ltd.
The animals were allocated without conscious bias to cages within the treatment groups.
They were housed in groups of one or four rats of the same sex.
Each animal was identified uniquely within the study by tail marking. Each cage label was color-coded and was identified uniquely with the study number, dose level and animal mark.
The animals were allowed to acclimatize to the conditions described below for at least 6 days before treatment. For those animals selected for this study, their body weights were in the range 154 to 172 g and they were approximately eight to twelve weeks of age prior to dosing (Day 1). The body weight variation did not exceed ± 20% of the mean body weight of any previously treated animals.
Animal Care and Husbandry:
Animals were housed inside a limited access rodent facility.
The animal room was kept at positive pressure with respect to the outside by its own supply of filtered fresh air, which was passed to atmosphere and not re-circulated. The temperature and relative humidity controls were set to maintain the range of 20 to 24°C and 40 to 70% respectively.
Artificial lighting was controlled to give a cycle of 12 hours continuous light and 12 hours continuous dark per 24 hours.
Periodic checks were made on the number of air changes in the animal rooms. Temperature and humidity were monitored daily.
The cages were solid bottomed polycarbonate cages with a stainless steel mesh lid. Each cage contained a quantity of autoclaved softwood bark-free fiber bedding. Cages, food hoppers, water bottles and bedding were changed at appropriate intervals.
The animals were allowed free access to a standard rodent diet (Teklad 2014C Diet), except for overnight prior to and approximately four hours after dosing. This diet contained no added antibiotic or other chemotherapeutic or prophylactic agent.
Potable water taken from the public supply was freely available via polycarbonate bottles fitted with sipper tubes.
Each cage of animals was provided with an Aspen chew blocks or balls for environmental enrichment. Chew blocks or balls were provided throughout the study and were replaced when necessary. Each cage of animals was provided with a plastic shelter for environmental enrichment, which was replaced at the same time as the cages.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- methylcellulose
- Remarks:
- 1% aqueous methyl cellulose.
- Details on oral exposure:
- Test Item Preparation and Analysis:
The test item was formulated at concentrations of 30 and 200 mg/mL in the vehicle and administered at a volume of 10 mL/kg body weight.
The test item formulations were prepared on the day of dosing.
The absorption of the test item was not determined.
Determination of the homogeneity, stability and purity of the test item or test item formulations were not undertaken as part of this study.
Study Design:
In the absence of data regarding the toxicity of the test item, 300 mg/kg was chosen as the starting dose.
Two single animals were treated as follows:
300 mg/kg dose level (1 female rat)
2000 mg/kg dose level (1 female rat)
In the absence of mortality or toxicity at a dose level of 2000 mg/kg, an additional group of animals was treated as follows:
2000 mg/kg dose level (4 female rats).
A total of five animals were therefore treated at a dose level of 2000 mg/kg in the study.
Dose Administration:
The appropriate dose volume of the test item was administered to each rat by oral gavage using a plastic syringe and plastic catheter.
A record of the weight of each formulation dispensed and the amount remaining after dosing was made. The balance of these two weights was compared with the predicted usage as a check that the doses had been administered correctly.
Formulations were stirred before and throughout the dosing procedure. - Doses:
- 300 and 2000 mg/kg
- No. of animals per sex per dose:
- 300 mg/kg: 1 female
2000 mg/kg: 5 females - Control animals:
- no
- Details on study design:
- Mortality:
Cages of rats were checked at least twice daily for any mortalities.
Clinical Observations:
Animals were observed soon after dosing and at frequent intervals (at least 0.5, 1, 2 and 4 hours after dosing) on Day 1. On subsequent days, animals were observed once in the
morning and again at the end of the experimental day (with the exception of Day 15 - morning only). The nature and severity, where appropriate, of the clinical signs and the time
were recorded at each observation.
All animals were observed for 14 days after dosing.
Body Weight:
The weight of each rat was recorded on Days -1, 1 (prior to dosing), 8 and 15. Individual weekly body weight changes and group mean body weights were calculated.
Terminal Investigations:
Method of Kill:
All animals were humanely killed on Day 15 by carbon dioxide asphyxiation.
Macroscopic Pathology:
All animals were subject to a macroscopic examination which consisted of opening the cranial, thoracic and abdominal cavities. The macroscopic appearance of the brain, cecum, duodenum, heart, kidneys, small and large intestine, liver, lungs and bronchi, spleen, stomach, subcutaneous tissue and urinary bladder was recorded.
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no deaths during the study.
- Clinical signs:
- other: There were no clinical signs of reaction to treatment throughout the study.
- Gross pathology:
- No abnormalities were noted in any animal at the macroscopic examination at study termination on Day 15.
Any other information on results incl. tables
Individual and group mean body weight (g):
Dose (mg/kg) |
Sex |
Animal Number |
Body weights (g) at Day |
||
1* |
8 |
15 |
|||
Sighting investigations |
|||||
300 |
Female |
221 |
162 |
186 |
195 |
2000 |
Female |
222 |
172 |
202 |
216 |
Main study |
|||||
2000 |
Female |
223 |
168 |
179 |
191 |
224 |
161 |
178 |
182 |
||
225 |
154 |
174 |
182 |
||
226 |
170 |
197 |
209 |
||
Mean |
163 |
182 |
191 |
* Prior to dosing
Individual body weight change (g)
Dose (mg/kg) |
Sex |
Animal Number |
Body weight change (g) at Day |
|
1-8 |
8-15 |
|||
Sighting investigations |
||||
300 |
Female |
221 |
24 |
9 |
2000 |
Female |
222 |
30 |
14 |
Main study |
||||
2000 |
Female |
223 |
11 |
12 |
224 |
17 |
4 |
||
225 |
20 |
8 |
||
226 |
27 |
12 |
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Remarks:
- EU CLP
- Conclusions:
- The acute median lethal oral dose (LD50) to rats of Mg-SiO was demonstrated to be greater than 2000 mg/kg body weight.
Mg-SiO is included in Category 5/Unclassified, according to the Globally Harmonised System (GHS). - Executive summary:
The study was performed to assess the acute oral toxicity of Mg-SiO, to the rat.
Fasted female rats received a single oral gavage dose of the test item, formulated in 1% aqueous methyl cellulose, at the following dose levels:
Sighting investigations: 300 and 2000 mg/kg body weight
Main study: Based on the results of the sighting investigations a further four fasted females were similarly dosed at 2000 mg/kg body weight.
During the study, clinical condition, body weight and macropathology investigations were undertaken.
Results:
There were no deaths, clinical signs of reaction to treatment or macroscopic abnormalities noted in any animal dosed at 300 or 2000 mg/kg and all animals were considered to have achieved satisfactory body weight gains throughout the study.
Conclusion:
The acute median lethal oral dose (LD50) to rats of Mg-SiO was demonstrated to be greater than 2000 mg/kg body weight.
Mg-SiO is included in Category 5/Unclassified, according to the Globally Harmonised System (GHS).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.